Navigation Links
Surgery Alone May Thwart Stage 1 Lung Cancer

Chemo, radiation may not be necessary for early malignancy, study finds

FRIDAY, Feb. 19 (HealthDay News) -- Surgery alone offers a reasonable overall level of survival for patients with stage 1 small cell lung cancer, a new study suggests.

Traditional treatment regimens for limited stage SCLS include chemotherapy and radiotherapy.

In this study, researchers analyzed U.S. National Cancer Institute data on the outcomes of 247 patients with stage 1 SCLC who had surgery to remove a lung (lobectomy).

The three- and five-year survival rates for patients who had surgery alone were 58.1 percent and 50.3 percent, respectively. The three- and five-year survival rates for patients who had surgery followed by radiotherapy (RT) were 64.9 percent and 57.1 percent, respectively.

"Based on our analysis, surgery without RT may offer a reasonable survival in a selected cohort of patients who undergo lobectomy, but this needs to be validated in a prospective settings," lead investigator Dr. James B. Yu, of Yale University, said in a news release.

"We cannot say conclusively whether patients who endure invasive surgeries can go without additional adjuvant radiation or chemotherapy, but looking forward, the study findings create a platform for advancing the understanding of the role of surgery in therapy."

The study results were published in the February issue of the Journal of Thoracic Oncology.

More information

The U.S. National Cancer Institute has more about small cell lung cancer.

-- Robert Preidt

SOURCE: International Association for the Study of Lung Cancer, news release, Feb. 16, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. One Surgery Often Enough for Peritonitis
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. Surgery for severe obesity saves lives
4. Some Epilepsy Patients Are Good Candidates for Surgery
5. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
6. Hypnosis Eases Pain of Breast Cancer Surgery
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
9. Cosmetic Surgery & Exotic Brazil
10. Small Incisions Make Heart Valve Surgery Safer
11. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: